From Safety to Efficacy:
Top Five Strategies to Improve Clinical Data Review
About this webinar
The industry is obsessed with speed and flexibility, and rightly so. Nothing exemplifies these characteristics, like the global race for COVID-19 interventions. PerkinElmer’s TIBCO Spotfire solutions have been at the forefront of clinical data visualization and analysis. The company is proud that its products are contributing to developing therapies and vaccines to address this viral pandemic.
This webinar will highlight how many of the challenges our clients experience during clinical trials can be tackled. Analytics can be tailored for specific clinical studies and therapeutic areas. With deep Spotfire, domain expertise and proven industry success, PerkinElmer wants to share the secret sauce on fast and flexible clinical data analysis.
Who should attend
- Clinical Safety, Director / VP
- Clinical Operations Director / VP
- Clinical Research & Development Director / VP
- Pharmacovigilance / Drug Safety Officer
- Clinical Pharmacology
- Quantitative Medicine
- Clinical Data Sciences
- Biostatistics and Data Management Director / VP
- Clinical / Medical Monitoring
- Clinical or R&D IT, Director or VP
What you will learn
In this webinar, attendees will learn how to:
- Accelerate your clinical data review
- Review safety and efficacy data in a centralized location
- Leverage an extensive library of therapeutic analytics
- Effectively perform an in-stream review of study data, to make smarter decisions faster
Featured Speakers
Brent Meyers
Brent Meyers has been building analytics solutions and leading technical delivery teams for 17 years. While he has focused on clinical analytics for the majority of his career, Meyers has also worked in the defense industry and US navy. He leads each analytics challenge with a focus on design and leveraging the best talent and technology for the solution. Meyers holds a BA from The Citadel and an MBA from Meredith College.
James Bullis
James Bullis has spent the last eight years in the field of Biomedical Informatics. During that time, he has worked for and with Pharmaceutical and Biotechnology companies in almost every aspect of drug development, from Pre-Clinical Discovery to Clinical Trials. He received his PhD from the University of Washington, Seattle and conducted postdoctoral work at Brandeis University.
Partner for this event
PerkinElmer
PerkinElmer’s advanced analytics and services solutions for Clinical Development help the world’s leading biopharmaceutical, medical device and diagnostics manufacturers discover new therapeutics faster by streamlining clinical operations, transforming risk into safety and enabling actionable decisions that can lead to better health outcomes.
Related webinars
More from Perkin Elmer.
Accelerate Biomarker Discovery: Learn How to Mine Data for Actionable Insights
PerkinElmer Signals Translational: All is FAIR in Biomarker Discovery and Patient Stratification
Evolving your Medical Data Review – SaaS for Patient Safety
Spiders, Swimmers, & More – Critical Oncology Data Insights (Part 2)
Spiders, Swimmers, & More – Critical Oncology Data Insights (Part 1)
Looking Beyond Risk in Risk-Based Monitoring
Predict and Act on Site Risks With Data-Driven Insights
Propel Medical Review with Guided Analytics – Part 1 of Series “Four Steps to Shorten Your Clinical Trials with Informatics”
Next Generation Clinical Data Review with TIBCO Spotfire®
Actionable & Adaptive RBM: PerkinElmer’s Comprehensive Approach to Risk-Based Monitoring